Market Newsdesk

CyberArk to Webcast Virtual Investor Events

NEWTON, Mass. & PETACH TIKVA, Israel–(BUSINESS WIRE)–CyberArk (NASDAQ: CYBR), the global leader in Identity Security, today announced that it will webcast its presentations at upcoming virtual conferences:

J.P. Morgan 49th Annual Global Technology, Media and Communications Conference

Monday, May 24, 2021

10:15 a.m. EDT

William Blair 41st Annual Growth Stock Conference

Tuesday, June 1, 2021

9:00 a.m. EDT

The presentations will be webcast, and an archive of the presentations will be available for a limited time under the “Events & Presentations” section on the company’s investor relations website (http://investors.cyberark.com/).

About CyberArk

CyberArk (NASDAQ: CYBR) is the global leader in Identity Security. Centered on privileged access management, CyberArk provides the most comprehensive security offering for any identity – human or machine – across business applications, distributed workforces, hybrid cloud workloads and throughout the DevOps lifecycle. The world’s leading organizations trust CyberArk to help secure their most critical assets. To learn more about CyberArk, visit https://www.cyberark.com, read the CyberArk blogs or follow on Twitter via @CyberArk, LinkedIn or Facebook.

Copyright © 2021 CyberArk Software. All Rights Reserved.All other brand names, product names, or trademarks belong to their respective holders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005205/en/

Investor Relations Contact:

Erica Smith

CyberArk

617-558-2132

[email protected]

Media Contact:

Liz Campbell

CyberArk

617-558-2191

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Networks Security Data Management Technology Software

MEDIA:

Logo

Eagle Point Credit Company Inc. Announces First Quarter 2021 Financial Results

GREENWICH, Conn.–(BUSINESS WIRE)–
Eagle Point Credit Company Inc. (the “Company”) (NYSE: ECC, ECCB, ECCW, ECCX, ECCY) today announced financial results for the quarter ended March 31, 2021, net asset value (“NAV”) as of March 31, 2021 and certain additional activity through April 30, 2021.

FIRST QUARTER 2021 HIGHLIGHTS

• Net investment income (“NII”) and realized capital gains of $0.28 per weighted average common share¹ for the first quarter.
• NAV per common share of $12.02 as of March 31, 2021, up from $11.18 per common share as of December 31, 2020.
• First quarter GAAP net income (inclusive of unrealized mark-to-market gains) of $35.2 million, or $1.09 per weighted average common share.
• Weighted average effective yield of the Company’s collateralized loan obligation (“CLO”) equity portfolio (excluding called CLOs), based on amortized cost, was 14.40% as of March 31, 2021. Weighted average expected yield of the Company’s CLO equity portfolio (excluding called CLOs), based on fair market value, was 17.80% as of March 31, 2021².
• Deployed $41.7 million in net capital and received $32.5 million in recurring cash distributions³ from the Company’s investment portfolio.
• 3 of the Company’s CLO equity investments were reset and 7 of the Company’s CLO equity investments were refinanced.
• Issued 242,268 shares of Series B Term Preferred Stock, pursuant to the Company’s “at-the-market” offering program, for total net proceeds to the Company of approximately $6.0 million.
• Completed an underwritten public offering of $39.0 million in aggregate principal amount of 6.75% notes due 2031 (“ECCW”), resulting in net proceeds to the Company of approximately $37.5 million.

SUBSEQUENT EVENTS

• NAV per common share is estimated to be between $12.62 and $12.72 as of April 30, 2021.
• Received $34.2 million of recurring cash distributions from the Company’s investment portfolio during April, an increase of 5% from the first quarter of 2021.
• Deployed $62.5 million in net capital during April.
• In April, the underwriters of the ECCW offering fully exercised their overallotment option, resulting in additional net proceeds to the Company of approximately $5.7 million.
• The Company issued 1,032,678 shares of its common stock, pursuant to the Company’s “at-the-market” offering program, for total net proceeds to the Company of approximately $12.6 million during April.
• Declared 25% increase in common stock monthly distributions to $0.10 per share commencing in July 2021.

“Our strong momentum from the second half of 2020 continued throughout the first quarter, as our NAV per common share increased by 8% from the end of 2020,” said Thomas Majewski, Chief Executive Officer. “For the quarter, we generated NII and realized capital gains of $0.28 per common share, after giving effect to a charge of $0.04 per share related to non-recurring expenses from our ECCW issuance. Excluding these items, we would have generated NII and realized capital gains of $0.32 per common share, in excess of our distribution. Our investment portfolio remained resilient and recurring cash flows from the portfolio increased. Given the strength of the Company’s recent financial performance and our outlook for the future, we were pleased to increase our monthly distributions by 25% to $0.10 per common share beginning in July.”

“Additionally, we further strengthened our liquidity position during the quarter as we successfully completed the offering of our 6.75% ECCW Notes due 2031, providing us with net proceeds of $43.2 million and lengthening our average debt maturity,” added Mr. Majewski. “With no debt maturities prior to October 2026 and over $13 million of cash on our balance sheet as of April 30, we are well positioned to take advantage of investment opportunities and generate attractive risk-adjusted returns.”

FIRST QUARTER 2021 RESULTS

The Company’s NII and realized capital gains for the quarter ended March 31, 2021 was $0.28 per weighted average common share. This compared to ($0.80) of NII and realized capital losses per weighted average common share for the quarter ended December 31, 2020, and $0.33 of NII and realized capital losses per weighted average common share for the quarter ended March 31, 2020.

The Company’s NII and realized capital gains for the quarter ended March 31, 2021 was reduced by $0.04 per weighted average common share due to the non-recurring expenses associated with the ECCW offering.

For the quarter ended March 31, 2021, the Company recorded GAAP net income of $35.2 million, or $1.09 per weighted average common share. Net income was comprised of total investment income of $17.2 million, total net unrealized appreciation (or unrealized mark-to-market gains in the value of the Company’s investments and certain liabilities at fair value) of $26.0 million and realized capital gains of $1.1 million, partially offset by expenses of $9.1 million.

NAV as of March 31, 2021 was $388.9 million, or $12.02 per common share, which is $0.84 per common share higher than the Company’s NAV as of December 31, 2020, and $5.90 per common share higher than the Company’s NAV as of March 31, 2020.

During the quarter ended March 31, 2021, the Company deployed $41.7 million in net capital, and converted 1 of its existing loan accumulation facilities into a CLO. The weighted average effective yield of new CLO equity investments made by the Company during the quarter, which includes a provision for credit losses, was 20.9% as measured at the time of investment.

During the quarter ended March 31, 2021, the Company received $32.5 million of recurring cash distributions from its investment portfolio, or $1.00 per weighted average common share, which was in excess of the Company’s aggregate distributions on its common stock and operating costs for the quarter. When including proceeds from called investments, the Company received cash distributions of $1.06 per weighted average common share during the quarter.

During the quarter ended March 31, 2021, 3 of the Company’s CLO equity investments were reset and 7 of the Company’s CLO equity investments were refinanced.

As of March 31, 2021, based on amortized cost, the weighted average effective yield on the Company’s CLO equity portfolio (excluding called CLOs) was 14.40%, compared to 11.05% as of December 31, 2020 and 14.77% as of March 31, 2020.

Pursuant to the Company’s “at-the-market” offering, the Company sold 242,268 shares of Series B Term Preferred Stock during the first quarter for total net proceeds to the Company of approximately $6.0 million.

PORTFOLIO STATUS

As of March 31, 2021, on a look-through basis, and based on the most recent CLO trustee reports received by such date, the Company had indirect exposure to approximately 1,620 unique corporate obligors. The largest look-through obligor represented 0.8% of the Company’s CLO equity and loan accumulation facility portfolio. The top-ten largest look-through obligors together represented 5.9% of the Company’s CLO equity and loan accumulation facility portfolio.

The look-through weighted average spread of the loans underlying the Company’s CLO equity and related investments was 3.56% as of March 2021, a decrease of 5 basis points from 3.61% as of December 2020.

As of March 31, 2021, the Company had debt and preferred securities outstanding which totaled approximately 32.6% of its total assets (less current liabilities). Over the long-term, management expects to operate the Company generally with leverage within a range of 25% to 35% of total assets under normal market conditions. Based on applicable market conditions at any given time, or should significant opportunities present themselves, the Company may incur leverage outside of this range, subject to applicable regulatory limits.

SECOND QUARTER 2021 PORTFOLIO ACTIVITY THROUGH APRIL 30, 2021 AND OTHER UPDATES

During April, the Company received $34.2 million of recurring cash distributions from its investment portfolio. As of April 30, 2021, some of the Company’s investments had not yet reached their payment date for the quarter. During April, the Company deployed $62.5 million in net capital.

As of April 30, 2021, the Company had approximately $13.4 million of cash available for investment.

Pursuant to the Company’s “at-the-market” offerings, the Company issued 1,032,678 shares of common stock during April for total net proceeds to the Company of approximately $12.6 million.

As previously published on the Company’s website, management’s estimate of the range of the Company’s NAV per common share as of April 30, 2021 was $12.62 to $12.72.

DISTRIBUTIONS

The Company paid a monthly distribution of $0.08 per common share on April 30, 2021 to stockholders of record as of April 12, 2021. Additionally, and as previously announced, the Company declared distributions of $0.08 per share of common stock payable on May 28, 2021 and June 30, 2021 to stockholders of record as of May 10, 2021 and June 10, 2021, respectively, and distributions of $0.10 per share of common stock payable on July 30, 2021, August 31, 2021 and September 30, 2021 to stockholders of record as of July 12, 2021, August 11, 2021 and September 10, 2021, respectively. The ability of the Company to declare and pay distributions is subject to a number of factors, including the Company’s results of operations.

The Company paid a monthly distribution of $0.161459 per share of the Company’s Series B Term Preferred Stock due 2026 (NYSE: ECCB) on April 30, 2021, to stockholders of record as of April 12, 2021. The distribution represented a 7.75% annualized rate, based on the $25 liquidation preference per share for the Series B Term Preferred Stock. Additionally, and as previously announced, the Company declared distributions of $0.161459 per share on its Series B Term Preferred Stock, payable on each of May 28, 2021, June 30, 2021, July 30, 2021, August 31, 2021 and September 30, 2021 to stockholders of record as of May 10, 2021, June 10, 2021, July 12, 2021, August 11, 2021 and September 10, 2021, respectively.

CONFERENCE CALL

The Company will host a conference call at 10:00 a.m. (Eastern Time) today to discuss the Company’s financial results for the quarter ended March 31, 2021, as well as a portfolio update.

All interested parties may participate in the conference call by dialing (877) 407-0789 (toll-free) or (201) 689-8562 (international), and referencing Conference ID 13719176 approximately 10 to 15 minutes prior to the call.

A live webcast will also be available on the Company’s website (www.eaglepointcreditcompany.com). Please go to the Investor Relations section at least 15 minutes prior to the call to register, download and install any necessary audio software.

An archived replay of the call will be available shortly afterwards until June 18, 2021. To hear the replay, please dial (844) 512-2921 (toll-free) or (412) 317-6671 (international). For the replay, enter Conference ID 13719176.

ADDITIONAL INFORMATION

The Company has made available on the investor relations section of its website, www.eaglepointcreditcompany.com (in the financial statements and reports section), its unaudited consolidated financial statements as of and for the period ended March 31, 2021. The Company has also filed this report with the Securities and Exchange Commission. The Company also published on its website (in the presentations and events section) an investor presentation, which contains additional information about the Company and its portfolio as of and for the quarter ended March 31, 2021.

ABOUT EAGLE POINT CREDIT COMPANY

The Company is a non-diversified, closed-end management investment company. The Company’s primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation, primarily through investment in equity and junior debt tranches of collateralized loan obligations. The Company is externally managed and advised by Eagle Point Credit Management LLC.

The Company makes certain unaudited portfolio information available each month on its website in addition to making certain other unaudited financial information available on its website (www.eaglepointcreditcompany.com). This information includes (1) an estimated range of the Company’s net investment income (“NII”) and realized gains or losses per share of common stock for each calendar quarter end, generally made available within the first fifteen days after the applicable calendar month end, (2) an estimated range of the Company’s NAV per share of common stock for the prior month end and certain additional portfolio-level information, generally made available within the first fifteen days after the applicable calendar month end, and (3) during the latter part of each month, an updated estimate of NAV, if applicable, and, with respect to each calendar quarter end, an updated estimate of the Company’s NII and realized gains or losses per share for the applicable quarter, if available.

FORWARD-LOOKING STATEMENTS

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the U.S. Securities and Exchange Commission (“SEC”). The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

¹ “Per weighted average common share” data are on a weighted average basis based on the average daily number of shares of common stock outstanding for the period and “per common share” refers to per share of the Company’s common stock.

² Weighted average effective yield is based on an investment’s amortized cost whereas weighted average expected yield is based on an investment’s fair market value as of the applicable period end as disclosed in the Company’s financial statements, which is subject to change from period to period. Please refer to the Company’s quarterly unaudited financial statements for additional disclosures.

³ “Recurring cash distributions” refers to the quarterly distributions received by the Company from its CLO equity and debt investments and distributions from loan accumulation facilities in excess of capital invested and excludes funds received from CLOs called.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005404/en/

Investor and Media Relations:

ICR

203-340-8510

[email protected]

www.eaglepointcreditcompany.com

KEYWORDS: Connecticut United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Posted on May 18, 2021 8:04 am

New Unique Zero Trust, macOS and Threat Hunting Updates Added to CrowdStrike’s Industry-Leading Falcon Platform

New Unique Zero Trust, macOS and Threat Hunting Updates Added to CrowdStrike’s Industry-Leading Falcon Platform

CrowdStrike updates macOS coverage, Falcon Complete and OverWatch dashboards and launches new capabilities with CrowdStrike Zero Trust

SUNNYVALE, Calif.–(BUSINESS WIRE)–CrowdStrike, a leader in cloud-delivered endpoint and workload protection, today announced multiple updates to its CrowdStrike Falcon® Platform including expanded macOS coverage, CrowdStrike Zero Trust, and the addition of the new Message Center for both Falcon Complete and Falcon OverWatch. CrowdStrike remains the only cloud-native vendor to offer a full spectrum of endpoint security capabilities — next-generation AV, endpoint detection and response, managed threat hunting, IT hygiene, threat intelligence and vulnerability management — all delivered via a powerful, intelligent single agent.

Comprehensive macOS Coverage

macOS is ubiquitous in enterprise environments and continues to gain adoption with end users and organizations looking to adopt cloud-flexible business capabilities. The growing adoption of macOS has been coupled with an increase in adversarial targeting of macOS environments via living off the land techniques and sophisticated malware-free approaches, which can enable threat actors to stay active and undetected in these environments. CrowdStrike has enhanced and expanded macOS capabilities across the platform including prevention, detection, IT hygiene, device control and enhanced visibility through CrowdStrike Zero Trust Assessment.

CrowdStrike Falcon enhancements for macOS environments include:

• Enhanced prevention and detection with mac script control
• Expanded IT hygiene coverage with Falcon Discover that now includes macOS application inventory, account monitoring, drive encryption and system capacity
• Zero Trust Assessment that displays the overall health of Mac endpoints and shares metrics with CrowdStrike partners for real-time conditional access enforcement
• M1 processor support
• Device Control for macOS Big Sur (Beta is scheduled to begin in June 2021)

CrowdStrike Zero Trust Solution

CrowdStrike continues to set the security standard for forward-looking organizations looking to deploy and maintain frictionless Zero Trust security without the burden of complexities. CrowdStrike Zero Trust is an innovative cloud-native solution to stop breaches in real-time for any endpoint, workload, or identity. It combines high fidelity attack correlation with near real time policy enforcement powered by the CrowdStrike Threat Graph®, which promotes a frictionless Zero Trust journey for organizations of any size.

With CrowdStrike Zero Trust, organizations can gain visibility of workforce identities across multi-directory, multi-cloud environments. CrowdStrike Zero Trust reduces dynamic friction with conditional access to reduce false positives, reducing the time to detect and resolve incidents by eliminating the need for complex, error-prone log analysis. This reduces alert fatigue, stops attack proliferation, and helps to better inform security teams.

OverWatch/Falcon Complete: Message Center & Dashboards

To enable frictionless, transparent, and secure communication with CrowdStrike’s managed services, CrowdStrike is excited to launch the new Message Center for Falcon Complete — CrowdStrike’s turnkey “endpoint protection as a service” that combines CrowdStrike’s endpoint protection technology with the skills and experience of the Falcon Team and Falcon OverWatch — the company’s managed threat hunting service.

The Message Center will act as a central hub for collaboration between CrowdStrike analysts and Falcon Complete or Falcon OverWatch customers, providing secure communication on emerging threats, adversary behaviors and potential incidents. Additionally, both managed service offerings will provide customers access to new intuitive dashboards that deliver visibility into day-to-day activities, helping security teams stay informed and understand threats more quickly. CrowdStrike has also introduced workflow and dashboard Application Programming Interfaces (APIs) to offer seamless integrations into existing workflows and ticketing systems.

“We continue to drive innovation and reinforce that the CrowdStrike Falcon platform is the market-leading solution that offers security teams the control, flexibility and comprehensive protection needed to stop breaches. The CrowdStrike Falcon platform provides customers with a true end-to-end solution that tackles today’s challenging threats in a way that helps enable organizations boost security operations and business maturity,” said Amol Kulkarni, CrowdStrike’s chief product officer.

For more information on CrowdStrike at RSA, visit the CrowdStrike website.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding benefits customers may experience from updates to the Falcon Platform. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release.

You should not rely on these forward-looking statements, as actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

About CrowdStrike

CrowdStrike, a global cybersecurity leader, is redefining security for the cloud era with an endpoint and workload protection platform built from the ground up to stop breaches. The CrowdStrike Falcon® platform’s single lightweight-agent architecture leverages cloud-scale artificial intelligence (AI) and offers real-time protection and visibility across the enterprise, preventing attacks on endpoints and workloads on or off the network. Powered by the proprietary CrowdStrike Threat Graph®, CrowdStrike Falcon correlates over 5 trillion endpoint-related events per week in real time from across the globe, fueling one of the world’s most advanced data platforms for security.

With CrowdStrike, customers benefit from better protection, better performance and immediate time-to-value delivered by the cloud-native Falcon platform.

There’s only one thing to remember about CrowdStrike: We stop breaches.

Qualifying organizations can gain full access to Falcon Prevent™ by starting a free trial.

Learn more: https://www.crowdstrike.com/

Follow us: Blog | Twitter

© 2021 CrowdStrike, Inc. All rights reserved. CrowdStrike, the falcon logo, CrowdStrike Falcon and CrowdStrike Threat Graph are marks owned by CrowdStrike, Inc. and registered with the United States Patent and Trademark Office, and in other countries. CrowdStrike owns other trademarks and service marks, and may use the brands of third parties to identify their products and services.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005423/en/

Media

CrowdStrike, Inc.

Kirsten Speas, 732-567-2023

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Data Management Security Technology Other Technology Software Networks Internet

MEDIA:

Logo

LifeWorks Declares May 2021 Cash Dividend

TORONTO–(BUSINESS WIRE)–
(TSX: MSI) LifeWorks Inc. (the “Company” or “LifeWorks”) announced today a cash dividend of $0.065 per share for the month of May 2021, to be paid on June 15, 2021 to holders of record of shares of MSI on May 31, 2021.

LifeWorks designates this dividend to be an “eligible dividend” pursuant to subsection 89(14) of the Income Tax Act (Canada) and similar provincial and territorial legislation. LifeWorks stock ticker symbol is currently reflective of the previous company name and will change on May 20, 2021.

About LifeWorks

LifeWorks is a global leader in delivering technology-enabled solutions that help clients support the total wellbeing of their people and build organizational resiliency. By improving lives, we improve business. Our solutions span employee and family assistance, health and wellness, recognition, pension and benefits administration, retirement and financial consulting, actuarial and investment services. LifeWorks employs over 6,000 employees who work with some 24,000 client organizations that use our services in more than 160 countries. LifeWorks is a publicly traded company on the Toronto Stock Exchange (TSX: MSI). For more information, visit lifeworks.com.

ID-CORP, ID-IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005460/en/

Heather MacDonald

LifeWorks

[email protected]

1-855-622-3327

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Technology Software

MEDIA:

Logo

Sparrow Pharmaceuticals Secures $50 Million Series A Financing

Names Industry Veteran Robert Jacks as President & CEO

• OrbiMed leads round
• Investment includes participation from RiverVest Venture Partners and U.S. Venture Partners
• Funds will be used to further develop Sparrow Pharmaceuticals’ proprietary HSD-1 inhibitor, SPI-62, for treatment of disorders of corticosteroid excess

PORTLAND, Ore.–(BUSINESS WIRE)–Sparrow Pharmaceuticals, an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess, today announced the closing of a $50 million Series A financing. OrbiMed led the investment round with participation by RiverVest Venture Partners and U.S. Venture Partners (USVP). This financing will allow the company to accelerate the development of its proprietary oral HSD-1 inhibitor, SPI-62, which targets the source of steroids that cause toxicity in key tissues. Sparrow also announced the appointment of biopharmaceutical industry veteran Robert Jacks as President and Chief Executive Officer.

“Excess corticosteroids can be devastating to patients, leading to poor health outcomes and diminished quality of life, whether the steroids are produced by the body, or administered as a medicine for autoimmune or inflammatory disease,” said Mr. Jacks, President and CEO of Sparrow. “With this new financing, we have an opportunity not only to address unmet medical needs in patients suffering from disorders of hypercortisolism, but also to potentially solve the 70-year-old puzzle of how to separate the life-changing efficacy of steroid medicines from their severe side effects.”

Sparrow was founded by Dr. David Katz, Chief Scientific Officer of Sparrow, to leverage underappreciated insights in corticosteroid biology. By inhibiting HSD-1, the predominant source of active intracellular steroids in key tissues, SPI-62 can potentially mitigate toxicities, possibly without significantly affecting the efficacy of steroid medicines.

“Sparrow Pharmaceuticals provides an unusual combination of groundbreaking science in a late-stage development opportunity,” added Dr. Klaus Veitinger, Chairman of Sparrow and a Venture Partner with OrbiMed. “With several Phase 2 readouts planned within the next few years, Sparrow has an opportunity to demonstrate its value proposition in a relatively short period of time.”

Sparrow Pharmaceuticals expects to initiate Phase 2 trials in patients with endogenous Cushing syndrome, autonomous cortisol secretion, and polymyalgia rheumatica in the next 12 months to assess SPI-62’s potential to address the unmet need of patients suffering the devastating effects of corticosteroid excess. To learn more about Sparrow Pharmaceuticals and its pipeline, visit the website at www.SparrowPharma.com.

About Sparrow Pharmaceuticals

Sparrow Pharmaceuticals was founded to spare patients the ravages of steroids. Leveraging underappreciated scientific insights into corticosteroid biology, the company is working to provide better treatment options for serious disorders of hypercortisolism, and to revolutionize the treatment of autoimmune and inflammatory conditions. Its lead product, SPI-62, is an oral, small molecule, novel therapeutic treatment designed to target the source of active intracellular corticosteroids in key tissues.

About OrbiMed

OrbiMed is a leading healthcare investment firm, with over $17 billion in assets under management. OrbiMed invests globally across the healthcare industry through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

About RiverVest

RiverVest is a leading venture capital firm building life science companies to address significant unmet needs of patients and deliver consistently strong returns to investors. With headquarters in St. Louis and offices in San Diego and Cleveland, RiverVest accesses forward-thinking research and clinical expertise at leading institutions across the country to found and fund biopharma and medical device companies.

About U.S. Venture Partners

U.S. Venture Partners (USVP) is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their ideas into world-changing companies. USVP has invested in over 500 companies spanning four decades. USVP focuses on early-stage start-ups that transform cybersecurity, enterprise software, consumer and healthcare. The USVP team consists of former entrepreneurs, technologists, corporate executives, and financial professionals who assist with strategy, scaling, team building, product development, and business development. USVP is based in Menlo Park, California.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005410/en/

Terri Clevenger

Westwicke, an ICR Company

[email protected]

203 856-4326

KEYWORDS: United States North America Oregon

INDUSTRY KEYWORDS: Pharmaceutical Health Clinical Trials

MEDIA:

Logo

Dalrada Corporation Reports 352% Increase in Third Quarter 2021 Financial Results

SAN DIEGO–(BUSINESS WIRE)–Dalrada Corporation (OTCQB: DFCO, “Dalrada”) reported its financial results for the third quarter of the fiscal year 2021 (ended March 31, 2021). With revenues of $1,588,329, this represents a 352% increase compared to the same period in 2020 ($351,324). This is the Company’s top-performing quarter since Dalrada shifted its mission to innovating global solutions in science, engineering, and technology in 2018.

Quarter-over-quarter revenue increased by 50% compared to the prior quarter three months ended December 30th, 2020 ($1,055,517). Dalrada continues to provide value with its products and services. As a result, Dalrada is achieving the objectives set for each business segment, despite the resurging disruptions caused by the pandemic to economies and particularly, supply chains.

Dalrada’s gross profit for the quarter was 46%. A decrease from the prior quarter (57%) was due to increases in raw materials, promotions to build customer loyalty, the added costs associated with the final stages of machine testing and quality assurance as well as the addition of two new subsidiaries, Pacific Stem Cells, LLC and International Health Group, Inc.

The net income gain is attributed to Dalrada’s expansion efforts with existing business segment maturity, growing sales, and its new acquisitions offering complementary products and services within the healthcare sector.

Dalrada’s operating subsidiaries Dalrada Precision, Dalrada Health Products, and Dalrada Technologies offer high-value innovative alternative solutions to businesses and consumers worldwide. With a global footprint in Malaysia, U.K., India, and United States, the Company is well-positioned to supply products and services with the ability to make a meaningful impact in environmental sustainability, healthcare, and business growth leveraging technology. Driven by passionate and dedicated people, Dalrada’s mission is to introduce disruptive solutions by offering a different approach to solving global problems.

Brian Bonar, Chairman & CEO of Dalrada, states, “Accelerating growth consistently amid the current business climate is a testament to Dalrada’s perseverance. The Company’s steadfast commitment to Corporate Social Responsibility and Inclusion is improving lives now and for future generations. Dalrada would like to thank its shareholders and the public for supporting the Company’s mission as it continues to create alternative innovations that advance industries including clean energy, engineering, science & health, and technology.”

During quarter three, and into the fourth quarter, Dalrada has made steady progress as an international innovation company. Advances and appointments include:

• Dalrada’s Executive Management – Dalrada’s CFO, Kyle McCollum, CPA, and David Pickett, EVP Sales & Business Development
• Dalrada Health’s cervical cancer screening study findings will be presented by Chief Medical Officer, Dr. Payal Keswarpu, at the 17^th World Congress for Cervical Pathology and Colposcopy
• Dalrada Health’s Empower Genomics launches with four new genomics tests
• Dalrada Health finalized acquisitions: Pacific Stem Cells, LLC, and International Healthcare Group (IHG)
• GlanHealth™ launched a personal and professional sanitizing product custom label program
• Dalrada Precision’s Likido^® Limited launches development of the Likido^®HOME water heater for 300% clean energy efficiency & significant carbon reduction, and Likido^®VOLT clean energy independent power generators securing the first sale with global dairy distributor Hidden Villa Ranch
• Dalrada Technology’s Prakat and Dragonchain partner on creating clean energy, fintech, and healthcare blockchain solutions, while continuing to win business with new and existing customers

Dalrada continues to attract global industry leaders to its Board of Directors. Recent appointments include:

• Tom Giles, Board of Directors – Technology & Heath
• Anthony Zolezzi, Board of Directors – Sustainability & Health

The Company’s financials reflect the assignment of 500,000 shares of restricted stock to each Dalrada Director of the Board for their services, for a total of $730,000 as non-cash compensation.

Bonar concludes, “Dalrada looks forward to sharing many more exciting announcements of industry advancements in the near future.”

For additional information on Dalrada and its subsidiaries, visit www.dalrada.com

About Dalrada (DFCO)

Dalrada Corporation (OTCQB: DFCO, “Dalrada”) solves complex global problems by producing innovation-focused and technologically centered solutions. Delivering next-generation manufacturing, engineering, healthcare, and technology products and services designed to propel growth, Dalrada is a team of industry experts and an organization built upon a strong foundation of capital management. The Company and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. For more information, visit www.dalrada.com or call 1-858-283-1253.

About Dalrada Health

A subsidiary of Dalrada Corporation, Dalrada Health is focused on solving health problems around the world. The company develops products and services that address the unmet needs of consumers due to accessibility, affordability, or availability. With operations in the U.S., Malaysia, and India, Dalrada Health reaches underserved markets through strong partnerships and the development of efficient supply chains. Dalrada Health is committed to solving universal health problems through improved methodologies resulting in products and services that benefit the global marketplace. For details, visit www.dalradahealth.com For information on GlanHealth™ visit www.glanhealth.com

About Dalrada Precision

A subsidiary of Dalrada Corporation, Dalrada Precision is focused on solution-based engineering and the customer experience. By continually delivering on its promises, the Company has created trust while building mutually successful long-term relationships. Dalrada Precision is a team of highly trained and committed individuals. The Company takes pride in solving the unique challenges of its customers and constantly improves and enhances its machining and manufacturing capabilities, ultimately becoming a key strategic partner of many businesses. For more information, please visit www.dalradaprecision.com.

About Likido^® Limited

Likido^® is an international technology company, developing advanced solutions for the harvesting and recycling of energy. Using its novel heat pump systems (patent pending), Likido^® is revolutionizing the renewable energy sector with the provision of innovative modular process technologies to maximize the capture and reuse of thermal energy for integrated heating and cooling applications. With uses across industrial, commercial, and residential sectors Likido^® seeks to provide cost savings and to minimize carbon emissions across supply chains. Likido’s novel technologies enable the effective recovery and recycling of process energy, mitigating climate change, and enhancing the quality of life through the provision of low-carbon heating and cooling systems. For more information, please visit www.likido.net.

About Prakat Solutions

Prakat Solutions Inc. is a technology solutions company specializing in test engineering, accessibility engineering, product engineering, and application modernization. The company partners with its clients to create transparent, value-based relationships by leveraging the extensive experience of its team and by providing innovative solutions in a wide range of technology domains that ultimately enable customers to successfully attain their business goals. The Prakat work culture is based on the belief that, “We believe in what we do; we do what we love.” Prakat is an ISO 9001-certified company with several Fortune 1000 customers. With its main engineering center in Bangalore, India, the Company also has offices in Dallas, Texas, Denver, Colorado, and San Diego, California. The Prakat team provides end-to-end product engineering services across various domains including banking and financial services, telecom, retail, healthcare, manufacturing, legal, and IT infrastructure. For more information, please visit www.prakat.com.

Disclaimer

Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management’s current views, are based on certain assumptions and may involve substantial risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the U.S. Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005433/en/

Denise Mahaffey

858.283.1253

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: General Health Health Engineering Technology Genetics Fitness & Nutrition Manufacturing Other Technology

MEDIA:

Logo

CrowdStrike Brings Behavioral Detections to Cloud Security Posture Management for the Industry’s First Adversary-Focused Cloud Security Solution

New features in Falcon Horizon leverage CrowdStrike’s powerful telemetry to deliver IOAs for cloud control plane security and provide DevOps tools for faster detection and remediation

SUNNYVALE, Calif.–(BUSINESS WIRE)–CrowdStrike, a leader in cloud-delivered endpoint and workload protection, today announced new features for CrowdStrike Falcon Horizon Cloud Security Posture Management (CSPM) that are powered by the vast, real-time telemetry of the CrowdStrike Security Cloud to deliver behavioral detections and attack patterns for a unique adversary-focused approach to securing the cloud control plane. These new capabilities include continuous threat detection, monitoring and correlation across cloud and on-premises environments, providing security teams the ability to cut through the noise of a multi-cloud environment and take the most effective action.

“Today’s application development lifecycle demands speed and agility, requiring teams to build applications and reconfigure cloud infrastructure on the fly and overwhelming security teams trying to gain control of resources to prevent breaches in the cloud,” said Michael Sentonas, chief technology officer at CrowdStrike. “To proactively protect organizations who are rapidly adopting the cloud, security teams must go beyond indicators of misconfiguration (IOMs) to understand the actors targeting them and the tools being used. Falcon Horizon is the first solution to deliver indicators of attack (IOAs) for the cloud control plane, arming customers with important data on threat activity leveraging cloud misconfigurations to pose serious risks across cloud services so they can quickly detect and stop breaches.”

Powered by CrowdStrike’s industry-leading threat intelligence, Falcon Horizon is the first CSPM solution to deliver an adversary-focused approach for continuous, in-depth control plane threat detection across an organization’s cloud accounts, services and users for AWS and Azure. Security teams receive real-time alerting and reporting on IOAs allowing them to better understand the adversaries and tactics that are targeting their organizations. Additionally, Falcon Horizon provides behavior-based tactics, techniques and procedures (TTPs) detections and guided remediation across the cloud estate, empowering security teams to proactively uncover hidden threats and conduct self-service threat hunting to more quickly spot suspicious activity and stop breaches.

Falcon Horizon’s new Confidence Scoring highlights the most critical Indicators of Attack. This new feature continuously aggregates, assesses and scores cloud control plane threats and changes in configurations to accurately identify malicious activity. The scores help security teams prioritize the most urgent threats, allowing them to rapidly identify, understand and take action against critical threat activity eliminating the time and resources needed for sifting through a barrage of inconsequential alerts.

Additional new capabilities for Falcon Horizon include:

• Integration at the speed of DevOps: Enables faster integration and remediation with organizations’ DevOps and collaboration tools through CrowdStrike’s single, powerful API to seamlessly onboard new cloud accounts to keep pace with new digital transformation initiatives.
• Unified visibility and control across cloud environments: Providesvisibility and control across multi-cloud and on-premises environments for simplified management and security policy enforcement from a single console, eliminating blind spots, more effectively preventing security incidents and ensuring application availability for any cloud.
• Prevention of misconfigurations and compliance violations: Proactively detects misconfigurations, cloud plane security threats and compliance violations with over 250 out-of-the-box adversary-focused policies, saving time and reducing operation costs.
• Guided remediation from security experts: Enables security teams to fix issues that leave cloud resources exposed with guided remediation and guardrails that enable developers to avoid critical mistakes.

To learn more about Falcon Horizon, visit here.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding the performance and benefits of CrowdStrike’s products. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release.

You should not rely on these forward-looking statements, as actual outcomes and results may differ materially from those anticipated or implied by these forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

About CrowdStrike

CrowdStrike, a global cybersecurity leader, is redefining security for the cloud era with an endpoint and workload protection platform built from the ground up to stop breaches. The CrowdStrike Falcon® platform’s single lightweight-agent architecture leverages cloud-scale artificial intelligence (AI) and offers real-time protection and visibility across the enterprise, preventing attacks on endpoints and workloads on or off the network. Powered by the proprietary CrowdStrike Threat Graph®, CrowdStrike Falcon correlates over 5 trillion endpoint-related events per week in real time from across the globe, fueling one of the world’s most advanced data platforms for security.

With CrowdStrike, customers benefit from better protection, better performance and immediate time-to-value delivered by the cloud-native Falcon platform.

There’s only one thing to remember about CrowdStrike: We stop breaches.

Qualifying organizations can gain full access to Falcon Horizon™ and Cloud Workload Protection by starting a free trial.

Learn more: https://www.crowdstrike.com/

Follow us: Blog | Twitter

© 2021 CrowdStrike, Inc. All rights reserved. CrowdStrike, the falcon logo, CrowdStrike Falcon and CrowdStrike Threat Graph are marks owned by CrowdStrike, Inc. and registered with the United States Patent and Trademark Office, and in other countries. CrowdStrike owns other trademarks and service marks, and may use the brands of third parties to identify their products and services.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005434/en/

Contact

CrowdStrike, Inc.

Angel Badagliacco, 408-313-5358

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Data Management Security Technology Other Technology Software Networks Internet

MEDIA:

Logo